Replies to post #496397 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

It is possible if 273 approved for multiple indications where mitochondrial malfunction is a problem.
Alz, Parkinsons, and all the other CNS diseases
also the cardio applications for which it was patented.
and if 371 has epic results for schizo, and follow on success with other CNS.
We could end up the CNS global powerhouse.
But first, we need to get one approval in the end zone!